Sponsor or institution

Clinical trials and research at Oneness Biotech Co., Ltd.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Oneness Biotech Co., Ltd. that are recruiting, at sites in 3 countries (most in Taiwan (2), United States (1), Australia (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Safety and tolerability of SNS851 in healthy adults. Phase 1 Melbourne Recruiting Feb 18, 2026
Evaluating the effects of FB825 for moderate-to-severe atopic dermatitis Phase 2 Fountain Valley, California and 15 other locations Recruiting May 3, 2024
Evaluating FB825 for allergic asthma in adults Phase 2 Kaohsiung City and 12 other locations Recruiting Aug 17, 2021

All recruiting trials (3)

Quick answers

How many clinical trials run by Oneness Biotech Co., Ltd. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Taiwan (2 trials), United States (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.